GLYX 13

Rapastinel (GLYX-13) is an N-methyl-D-aspartate receptor (NMDAR) modulator that has characteristics of a glycine site partial agonist.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
GLYX 13(CAS 117928-94-6)

CAT No: R0954

CAS No:117928-94-6

Synonyms/Alias:Rapastinel;117928-94-6;GLYX 13;GLYX-13;GLYX13;TPPT-amide;Rapastinelum;GLYX-13 peptide;UNII-6A1X56B95E;L-Threoninamide, L-threonyl-L-prolyl-L-prolyl-;Rapastinel [USAN:INN];GLYX-13 trifluoroacetate;RAPASTINEL [INN];RAPASTINEL [USAN];RAPASTINEL [WHO-DD];6A1X56B95E;(2S)-1-[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]pyrrolidine-2-carboxamide;(S)-N-((2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)-1-((S)-1-((2S,3R)-2-amino-3-hydroxybutanoyl)pyrrolidine-2-carbonyl)pyrrolidine-2-carboxamide;L-THREONYL-L-PROLYL-L-PROLYL-L-THREONINAMIDE;(2S,3R)-2-(((2S)-1-((2S)-1-((2S,3R)-2-amino-3-hydroxybutanoyl)pyrrolidine-2-carbonyl)pyrrolidin-2-yl)formamido)-3-hydroxybutanamide;(2S,3R)-2-{[(2S)-1-[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanamide;GLYX13;Rapastinel;Rapastinel (GLYX-13);Rapastinel(GLYX-13)?;TPPT-amide trifluoroacetate;SCHEMBL1668190;CHEMBL3544917;EX-A794;GIBQQARAXHVEGD-BSOLPCOYSA-N;DTXSID501030481;MFCD12912477;MFCD20527320;s6907;AKOS024457610;CS-5507;DB11801;NCGC00485669-01;AC-32874;AS-55920;HY-16728;NS00072942;Q5513673;BRD-K02206208-001-01-4;L-Threonyl-L-prolyl-L-prolyl-L-threoninamide trifluoroacetate; Thr-Pro-Pro-Thr-NH2 trifluoroacetate;

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C18H31N5O6
M.W/Mr.
413.5
Sequence
One Letter Code:TPPT
Three Letter Code:H-Thr-Pro-Pro-Thr-NH2
Biological Activity
NMDA receptor partial agonist that acts at the glycine site. Simultaneously acts as a promoter of the induction of long-term potentiation (LTP) and as a suppressor of long-term depression (LTD). Exhibits nootropic, neuroprotective and antinociceptive activity, and enhances learning, memory and cognition in vivo. Brain penetrant.
Long-term Storage Conditions
Soluble to 2 mg/ml in water
Shipping Condition
Room temperature in continental US; may vary elsewhere.
InChI
InChI=1S/C18H31N5O6/c1-9(24)13(19)18(29)23-8-4-6-12(23)17(28)22-7-3-5-11(22)16(27)21-14(10(2)25)15(20)26/h9-14,24-25H,3-8,19H2,1-2H3,(H2,20,26)(H,21,27)/t9-,10-,11+,12+,13+,14+/m1/s1
InChI Key
GIBQQARAXHVEGD-BSOLPCOYSA-N

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide CDMOPeptide Modification ServicescGMP Peptide ServiceEpitope Mapping ServicesCustom Conjugation ServicePeptide Analysis ServicesPeptide Nucleic Acids SynthesisPeptide Synthesis Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers